Translational and Clinical Pharmacology, published by KSCPT, is an esteemed journal that serves as a vital source of knowledge in the field of pharmacology, particularly focusing on the translational aspects that bridge laboratory research and clinical applications. Established in 2014, this journal aims to disseminate high-quality research and reviews pertaining to drug development, therapeutics, and the underlying mechanisms of action in the medical realm. With an ISSN of 2289-0882 and an E-ISSN of 2383-5427, it holds a significant position with a Q3 ranking in the pharmacology category as of 2023, emphasizing its role in advancing scientific understanding within this crucial discipline. While it operates as a traditional subscription-based journal, its output remains accessible through various academic platforms, contributing to the global discourse in pharmacology. Researchers, professionals, and students will find value in its insightful articles and comprehensive studies, underscoring the journal’s commitment to enhancing pharmacological knowledge and practice.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

SOUTH AFRICAN STATISTICAL JOURNAL, published by the SOUTH AFRICAN STATISTICAL ASSOCIATION, stands as a pivotal platform for advancing the field of statistics and probability, particularly within the South African context. Operating since 1996, this journal aims to bridge the gap between theoretical advancements and practical applications of statistical methodologies. Although currently categorized in the Q4 quartile in both Statistics and Probability, as well as Statistics, Probability and Uncertainty, it continues to serve as a crucial resource for researchers, practitioners, and students alike, encouraging the dissemination of research that tackles real-world statistical challenges. Despite not being an open access publication, the journal’s contributions are vital for anyone interested in the evolving landscape of statistical sciences, with each issue delving into diverse topics relevant to the field. With an ISSN of 0038-271X and an E-ISSN of 1996-8450, it invites the academic community to deepen their understanding and engagement with statistical practices through its thoughtfully curated content. The journal's emphasis on collaboration and knowledge-sharing is key in fostering innovation and enhancing statistical literacy within and beyond South Africa.

CLINICAL PHARMACOKINETICS, published by ADIS INT LTD, is a premier journal dedicated to the field of pharmacology, with a distinguished reputation since its inception in 1976. With an impressive impact factor and categorized in the Q1 quartile for both general pharmacology and medical pharmacology, this journal ranks #29 out of 272 and #53 out of 313 in its respective categories in Scopus, highlighting its high academic influence and the quality of research it publishes. CLINICAL PHARMACOKINETICS serves as a vital resource for researchers, professionals, and students interested in the latest advancements in drug metabolism, therapeutic efficacy, and clinical applications of pharmacokinetic studies. As it continues to evolve through 2024 and beyond, the journal remains committed to fostering a deeper understanding of pharmacotherapy and its implications in clinical practice. While it does not currently offer open access, the journal ensures that cutting-edge research is accessible through various academic platforms.

JOURNAL OF AGRICULTURAL BIOLOGICAL AND ENVIRONMENTAL STATISTICS, published by SPRINGER, serves as a vital platform for advancing knowledge in the quantitative study of agricultural, biological, and environmental phenomena. With an ISSN of 1085-7117 and an impressive e-ISSN of 1537-2693, this journal encompasses a broad scope of research that applies statistical methodologies to address complex challenges within the field. Operating out of the United States, the journal demonstrates its academic rigor and relevance, evidenced by its Q2 rankings across multiple categories in 2023, including Agricultural and Biological Sciences, Applied Mathematics, and Environmental Science. Researchers and practitioners in these fields will find significant value in the journal’s focus on integrating statistical techniques and innovative analyses, fostering interdisciplinary collaboration. Published continuously since 1996, it remains committed to publishing high-quality articles that not only contribute to theoretical advancements but also offer practical solutions, thereby enhancing the understanding of critical issues in agriculture, biology, and environmental science.

STATISTICAL METHODS IN MEDICAL RESEARCH is a leading academic journal dedicated to advancing the field of statistical methodologies as they apply to medical research. Published by SAGE Publications Ltd, this prestigious journal focuses on innovative statistical techniques that are pivotal for health-related data analysis and interpretation. With its Q1 ranking in Epidemiology, Health Information Management, and Statistics and Probability as of 2023, it stands out as a vital resource for researchers and practitioners alike. The journal, which has been in circulation since 1992, is widely recognized for its robust contributions to evidence-based medicine and public health, ensuring that practitioners have access to cutting-edge research. Although it currently does not offer Open Access options, the high-impact nature indicated by its rankings and percentile positions solidifies its importance as a go-to source for statistical theories and applications in health research. Researchers, healthcare professionals, and students are encouraged to explore the rich content of this journal to stay abreast of the latest advancements and methodologies.

Expert Review of Precision Medicine and Drug Development, published by Taylor & Francis Ltd, is a valuable academic resource that thrives at the intersection of pharmacology, genetics, and molecular medicine. Since its inception in 2016, this journal has rapidly become a pivotal platform for researchers and practitioners aiming to advance the field of drug development through innovative precision medicine strategies. With a broad focus encompassing the latest advancements in drug discovery and genetic research, it operates within a competitive landscape, evidenced by its recent category quartile rankings where it holds Q4 in Drug Discovery, Genetics, and Molecular Medicine, alongside a Q3 ranking in Pharmacology for the year 2023. The journal offers a unique opportunity for scholars to share insights and foster collaborations that can lead to breakthroughs in therapeutic approaches. Although not an open-access journal, it maintains a commitment to disseminating outstanding research to a wide audience. By fostering a rigorous peer-review process, the journal aims to enhance the quality and impact of publications within these critical areas of medicine, making it an essential read for anyone involved in healthcare and pharmaceutical advancements.

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

Korean Journal of Applied Statistics, published by the Korean Statistical Society, is a prominent journal dedicated to advancing the field of applied statistics. ISSN 1225-066X (Print) and E-ISSN 2383-5818 (Online), this journal serves as a vital platform for disseminating high-quality research that addresses the latest methodologies, applications, and innovations in statistical practices. Though currently not an open-access journal, it aims to foster collaboration among statisticians, researchers, and practitioners by providing rigorous peer-reviewed articles that enhance understanding and application of statistical techniques across various disciplines. With a commitment to integrating theory and practice, the Korean Journal of Applied Statistics stands as a crucial resource for those seeking to influence the evolving landscape of statistical research and its applications in Korea and beyond.

Welcome to the Electronic Journal of Applied Statistical Analysis, a pivotal platform for researchers and practitioners in the domains of Statistics and Probability, as well as Modeling and Simulation. Published by Università del Salento in Italy, this journal has been dedicated to disseminating valuable insights and advancements in applied statistical methodology since its inception in 2008. With its ISSN of 2070-5948, the journal operates within an esteemed academic framework, contributing significantly to the field despite its current Q4 ranking in both Statistics and Probability and Modeling and Simulation categories as of 2023. As we continue to explore complex statistical models and simulation techniques, the journal encourages submissions that advance theoretical and practical understandings, inviting the global academic community to engage with transformative research endeavors. For those looking to stay informed and ahead in the dynamic world of applied statistics, the Electronic Journal of Applied Statistical Analysis is an essential resource.